<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE Annotation PUBLIC "-//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN" "../GENIAtypes/GENIA_event_20.dtd">
<Annotation created="07/07/2006" creator="Junko Matsuura" annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=8573121">
<PubmedArticleSet>
<PubmedArticle>
<MedlineCitation>
<PMID>8573121</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Inhibition of <term sem="Other" id="T1" lex="NF-kappa_B_activation"><term sem="Protein_complex" id="T2" lex="NF-kappa_B">NF-kappa B</term> activation</term> in <term sem="Cell_cultured" id="T3" lex="human_T-cell_line">human T-cell lines</term> by <term sem="Organic_compound_other" id="T4" lex="anetholdithiolthione">anetholdithiolthione</term>.</sentence>
<event id="E1">
<type class="Positive_regulation" />
<theme idref="T2" />
<clue>Inhibition of NF-kappa B <clueType>activation</clueType> in human T-cell lines by anetholdithiolthione.</clue>
</event>
<event id="E2">
<type class="Negative_regulation" />
<theme idref="E1" />
<cause idref="T4" />
<clue><clueType>Inhibition</clueType> <linkTheme>of</linkTheme> NF-kappa B activation <clueLoc>in human T-cell lines</clueLoc> <linkCause>by</linkCause> anetholdithiolthione.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2"><term sem="Protein_complex" id="T5" lex="nuclear_factor_(NF)-kappa_B">Nuclear factor (NF)-kappa B</term> is a <term sem="Protein_family_or_group" id="T6" lex="redox_sensitive_cytosolic_transcription_factor"><term sem="Other" id="A1">redox</term> sensitive cytosolic transcription factor</term>.</sentence>
<event id="E3">
<type />
<theme idref="T5" />
<cause idref="A1" />
<clue>Nuclear factor (NF)-kappa B is a redox <clueType>sensitive</clueType> <corefTheme>cytosolic transcription factor</corefTheme>.</clue>
<comment>SENSITIVITY</comment>
</event>
<sentence id="S3"><term sem="Other" id="A2">Redox</term> regulation of <term sem="Protein_complex" id="T7" lex="NF-kappa_B">NF-kappa B</term> has been implicated in the activation of the <term sem="Virus" id="T8" lex="human_immuno-deficiency_virus">human immuno-deficiency virus</term> (<term sem="Virus" id="T9" lex="HIV">HIV</term>).</sentence>
<event id="E4">
<type class="Regulation" />
<theme idref="T7" />
<cause idref="A2" />
<clue>Redox <clueType>regulation</clueType> <linkTheme>of</linkTheme> NF-kappa B has been implicated in the activation of the human immuno-deficiency virus (HIV).</clue>
</event>
<event id="E5">
<type class="Positive_regulation" />
<theme idref="T9" />
<clue>Redox regulation of NF-kappa B has been implicated in the <clueType>activation</clueType> <linkTheme>of</linkTheme> the human immuno-deficiency virus (HIV).</clue>
</event>
<event id="E6">
<type class="Correlation" />
<theme idref="E5" />
<theme idref="E4" />
<clue>Redox regulation of NF-kappa B has been <clueType>implicated</clueType> <linkTheme>in</linkTheme> the activation of the human immuno-deficiency virus (HIV).</clue>
</event>
<sentence id="S4">Therefore, inhibition of <term sem="Other" id="T10" lex="NF-kappa_B_activation"><term sem="Protein_complex" id="T11" lex="NF-kappa_B">NF-kappa B</term> activation</term> may be an effective strategy for <term sem="Other" id="T12" lex="acquired_immunodeficiency_syndrome_therapy"><term sem="Other" id="T13" lex="acquired_immunodeficiency_syndrome">acquired immunodeficiency syndrome</term> therapy</term>.</sentence>
<event id="E7">
<type class="Positive_regulation" />
<theme idref="T11" />
<clue>Therefore, inhibition of NF-kappa B <clueType>activation</clueType> may be an effective strategy for acquired immunodeficiency syndrome therapy.</clue>
</event>
<event id="E8">
<type class="Negative_regulation" />
<theme idref="E7" />
<clue>Therefore, <clueType>inhibition</clueType> <linkTheme>of</linkTheme> NF-kappa B activation may be an effective strategy for acquired immunodeficiency syndrome therapy.</clue>
</event>
<sentence id="S5"><term sem="Organic_compound_other" id="T14" lex="anetholdithiolthione">Anetholdithiolthione</term> (<term sem="Organic_compound_other" id="T15" lex="ADT">ADT</term>, <term sem="Organic_compound_other" id="T16" lex="5-[p-methoxyphenyl]-3H-1,2-dithiol-3-thione">5-[p-methoxyphenyl]-3H-1,2-dithiol-3-thione</term>) is an <term sem="Organic_compound_other" id="T17" lex="antioxidant">antioxidant</term> which has been used to protect against <term sem="Organic_compound_other" id="A4">acetaminophen</term>- and <term sem="Inorganic_compound" id="A5">CCl4</term>-induced <term sem="Other" id="A6">hepatotoxicity</term>, <term sem="Other" id="T19" lex="lipid_peroxidation"><term sem="Lipid" id="T20" lex="lipid">lipid</term> peroxidation</term>, <term sem="Other" id="T21" lex="radiation_injury">radiation injury</term>, and also has been used clinically as an <term sem="Organic_compound_other" id="T22" lex="anti-choleretic_agent">anti-choleretic agent</term>.</sentence>
<event id="E9">
<type class="Positive_regulation" />
<theme idref="A6" />
<cause idref="A4" />
<clue>Anetholdithiolthione (ADT, 5-[p-methoxyphenyl]-3H-1,2-dithiol-3-thione) is an antioxidant which has been used to protect against acetaminophen- and CCl4-<clueType>induced</clueType> hepatotoxicity, lipid peroxidation, radiation injury, and also has been used clinically as an anti-choleretic agent.</clue>
<comment>NER: T18 DEL</comment>
</event>
<event id="E10">
<type class="Positive_regulation" />
<theme idref="A6" />
<cause idref="A5" />
<clue>Anetholdithiolthione (ADT, 5-[p-methoxyphenyl]-3H-1,2-dithiol-3-thione) is an antioxidant which has been used to protect against acetaminophen- and CCl4-<clueType>induced</clueType> hepatotoxicity, lipid peroxidation, radiation injury, and also has been used clinically as an anti-choleretic agent.</clue>
</event>
<event id="E11">
<type class="Negative_regulation" />
<theme idref="E9" />
<cause idref="T15" />
<clue>Anetholdithiolthione (ADT, 5-[p-methoxyphenyl]-3H-1,2-dithiol-3-thione) is an antioxidant which has been used to <clueType>protect</clueType> <linkTheme>against</linkTheme> acetaminophen- and CCl4-induced hepatotoxicity, lipid peroxidation, radiation injury, and also has been used clinically as an anti-choleretic agent.</clue>
</event>
<event id="E12">
<type class="Negative_regulation" />
<theme idref="E10" />
<cause idref="T15" />
<clue>Anetholdithiolthione (ADT, 5-[p-methoxyphenyl]-3H-1,2-dithiol-3-thione) is an antioxidant which has been used to <clueType>protect</clueType> <linkTheme>against</linkTheme> acetaminophen- and CCl4-induced hepatotoxicity, lipid peroxidation, radiation injury, and also has been used clinically as an anti-choleretic agent.</clue>
</event>
<event id="E13">
<type class="Negative_regulation" />
<theme idref="T19" />
<cause idref="T15" />
<clue>Anetholdithiolthione (ADT, 5-[p-methoxyphenyl]-3H-1,2-dithiol-3-thione) is an antioxidant which has been used to <clueType>protect</clueType> <linkTheme>against</linkTheme> acetaminophen- and CCl4-induced hepatotoxicity, lipid peroxidation, radiation injury, and also has been used clinically as an anti-choleretic agent.</clue>
</event>
<event id="E14">
<type class="Negative_regulation" />
<theme idref="T21" />
<cause idref="T15" />
<clue>Anetholdithiolthione (ADT, 5-[p-methoxyphenyl]-3H-1,2-dithiol-3-thione) is an antioxidant which has been used to <clueType>protect</clueType> <linkTheme>against</linkTheme> acetaminophen- and CCl4-induced hepatotoxicity, lipid peroxidation, radiation injury, and also has been used clinically as an anti-choleretic agent.</clue>
</event>
<sentence id="S6">The present study examined the effect of <term sem="Other" id="T23" lex="ADT_pretreatment"><term sem="Organic_compound_other" id="T24" lex="ADT">ADT</term> pretreatment</term> on <term sem="Other" id="T25" lex="NF-kappa_B_activation"><term sem="Protein_complex" id="T26" lex="NF-kappa_B">NF-kappa B</term> activation</term> in response to a variety of stimuli such as <term sem="Inorganic_compound" id="T27" lex="H2O2">H2O2</term>, <term sem="Organic_compound_other" id="T28" lex="phorbol_myristate_acetate">phorbol myristate acetate</term> (<term sem="Organic_compound_other" id="T29" lex="PMA">PMA</term>) or <term sem="Protein_molecule" id="T30" lex="tumor_necrosis_factor_alpha">tumor necrosis factor alpha</term> (<term sem="Protein_molecule" id="T31" lex="TNF_alpha">TNF alpha</term>).</sentence>
<event id="E15">
<type class="Positive_regulation" />
<theme idref="T26" />
<cause idref="T27" />
<clue>The present study examined the effect of ADT pretreatment on NF-kappa B <clueType>activation</clueType> <linkCause>in response to</linkCause> a variety of stimuli such as H2O2, phorbol myristate acetate (PMA) or tumor necrosis factor alpha (TNF alpha).</clue>
</event>
<event id="E16">
<type class="Positive_regulation" />
<theme idref="T26" />
<cause idref="T29" />
<clue>The present study examined the effect of ADT pretreatment on NF-kappa B <clueType>activation</clueType> <linkCause>in response to</linkCause> a variety of stimuli such as H2O2, phorbol myristate acetate (PMA) or tumor necrosis factor alpha (TNF alpha).</clue>
</event>
<event id="E17">
<type class="Positive_regulation" />
<theme idref="T26" />
<cause idref="T31" />
<clue>The present study examined the effect of ADT pretreatment on NF-kappa B <clueType>activation</clueType> <linkCause>in response to</linkCause> a variety of stimuli such as H2O2, phorbol myristate acetate (PMA) or tumor necrosis factor alpha (TNF alpha).</clue>
</event>
<event id="E18">
<type class="Artificial_process" />
<theme idref="T24" />
<clue>The present study examined the effect of ADT <clueType>pretreatment</clueType> on NF-kappa B activation in response to a variety of stimuli such as H2O2, phorbol myristate acetate (PMA) or tumor necrosis factor alpha (TNF alpha).</clue>
</event>
<event id="E19">
<type class="Regulation" />
<theme idref="E15" />
<cause idref="E18" />
<clue>The present study examined the <clueType>effect</clueType> <linkCause>of</linkCause> ADT pretreatment <linkTheme>on</linkTheme> NF-kappa B activation in response to a variety of stimuli such as H2O2, phorbol myristate acetate (PMA) or tumor necrosis factor alpha (TNF alpha).</clue>
</event>
<event id="E20">
<type class="Regulation" />
<theme idref="E16" />
<cause idref="E18" />
<clue>The present study examined the <clueType>effect</clueType> <linkCause>of</linkCause> ADT pretreatment <linkTheme>on</linkTheme> NF-kappa B activation in response to a variety of stimuli such as H2O2, phorbol myristate acetate (PMA) or tumor necrosis factor alpha (TNF alpha).</clue>
</event>
<event id="E21">
<type class="Regulation" />
<theme idref="E17" />
<cause idref="E18" />
<clue>The present study examined the <clueType>effect</clueType> <linkCause>of</linkCause> ADT pretreatment <linkTheme>on</linkTheme> NF-kappa B activation in response to a variety of stimuli such as H2O2, phorbol myristate acetate (PMA) or tumor necrosis factor alpha (TNF alpha).</clue>
</event>
<sentence id="S7"><term sem="Organic_compound_other" id="T32" lex="PMA">PMA</term> and <term sem="Other" id="T33" lex="TNF_alpha_induced_activation"><term sem="Protein_molecule" id="T34" lex="TNF_alpha">TNF alpha</term> induced activation</term> of <term sem="Protein_complex" id="T35" lex="(NF)-kappa_B">(NF)-kappa B</term> in human <term sem="Cell_cultured" id="T36" lex="Jurkat_T-cell">Jurkat T-cells</term> was partially inhibited by <term sem="Organic_compound_other" id="T37" lex="ADT">ADT</term> (0.1 mM) pretreatment.</sentence>
<event id="E22">
<type class="Positive_regulation" />
<theme idref="T35" />
<clue>PMA and TNF alpha induced <clueType>activation</clueType> <linkTheme>of</linkTheme> (NF)-kappa B in human Jurkat T-cells was partially inhibited by ADT (0.1 mM) pretreatment.</clue>
</event>
<event id="E23">
<type class="Positive_regulation" />
<theme idref="E22" />
<cause idref="T32" />
<clue>PMA and TNF alpha <clueType>induced</clueType> activation of (NF)-kappa B <clueLoc>in human Jurkat T-cells</clueLoc> was partially inhibited by ADT (0.1 mM) pretreatment.</clue>
</event>
<event id="E24">
<type class="Positive_regulation" />
<theme idref="E22" />
<cause idref="T34" />
<clue>PMA and TNF alpha <clueType>induced</clueType> activation of (NF)-kappa B <clueLoc>in human Jurkat T-cells</clueLoc> was partially inhibited by ADT (0.1 mM) pretreatment.</clue>
</event>
<event id="E25">
<type class="Artificial_process" />
<theme idref="T37" />
<clue>PMA and TNF alpha induced activation of (NF)-kappa B in human Jurkat T-cells was partially inhibited by ADT (0.1 mM) <clueType>pretreatment</clueType>.</clue>
</event>
<event id="E26">
<type class="Negative_regulation" />
<theme idref="E23" />
<cause idref="E25" />
<clue>PMA and TNF alpha induced activation of (NF)-kappa B in human Jurkat T-cells was partially <clueType>inhibited</clueType> <linkCause>by</linkCause> ADT (0.1 mM) pretreatment.</clue>
</event>
<event id="E27">
<type class="Negative_regulation" />
<theme idref="E24" />
<cause idref="E25" />
<clue>PMA and TNF alpha induced activation of (NF)-kappa B in human Jurkat T-cells was partially <clueType>inhibited</clueType> <linkCause>by</linkCause> ADT (0.1 mM) pretreatment.</clue>
</event>
<sentence id="S8"><term sem="Organic_compound_other" id="T38" lex="ADT">ADT</term> (0.1 mM) also inhibited <term sem="Inorganic_compound" id="T39" lex="H2O2">H2O2</term> induced activation of the <term sem="Protein_family_or_group" id="T40" lex="transcription_factor">transcription factor</term> in the <term sem="Cell_cultured" id="T41" lex="peroxide_sensitive_human_Wurzburg_T-cell"><term sem="Other" id="A21">peroxide</term> sensitive <term sem="Cell_natural" id="A22">human Wurzburg T-cells</term></term>.</sentence>
<event id="E28">
<type class="Positive_regulation" />
<theme idref="T40" />
<cause idref="T39" />
<clue>ADT (0.1 mM) also inhibited H2O2 <linkCause>induced</linkCause> <clueType>activation</clueType> <linkTheme>of</linkTheme> the transcription factor <clueLoc>in the peroxide sensitive human Wurzburg T-cells.</clueLoc></clue>
</event>
<event id="E29">
<type class="Negative_regulation" />
<theme idref="E28" />
<cause idref="T38" />
<clue>ADT (0.1 mM) also <clueType>inhibited</clueType> H2O2 induced activation of the transcription factor in the peroxide sensitive human Wurzburg T-cells.</clue>
</event>
<event id="E31">
<type />
<theme idref="A22" />
<cause idref="A21" />
<clue>ADT (0.1 mM) also inhibited H2O2 induced activation of the transcription factor in the peroxide <clueType>sensitive</clueType> human Wurzburg T-cells.</clue>
<comment>SENSITIVITY</comment>
</event>
<sentence id="S9">Furthermore, <term sem="Organic_compound_other" id="T42" lex="ADT">ADT</term> treated <term sem="Cell_cultured" id="T43" lex="Wurzburg_cell">Wurzburg cells</term> had significantly higher <term sem="Other" id="T44" lex="glutathione_level"><term sem="Peptide" id="T45" lex="glutathione">glutathione</term> levels</term> as compared with <term sem="Cell_natural" id="T46" lex="untreated_cell">untreated cells</term>.</sentence>
<event id="E32">
<type class="Artificial_process" />
<theme idref="T45" />
<theme idref="T42" />
<clue>Furthermore, ADT <clueType>treated</clueType> Wurzburg cells had significantly higher glutathione levels as compared with untreated cells.</clue>
</event>
<event id="E51">
<type class="Positive_regulation" />
<theme idref="T45" />
<cause idref="E32" />
<clue>Furthermore, ADT treated Wurzburg cells <clueType>had</clueType> significantly <clueType>higher</clueType> glutathione levels as compared with untreated cells.</clue>
</event>
<sentence id="S10"><term sem="Inorganic_compound" id="T47" lex="H2O2">H2O2</term> induced <term sem="Other" id="T48" lex="lipid_peroxidation">lipid peroxidation</term> in <term sem="Cell_cultured" id="T49" lex="Wurzburg_cell">Wurzburg cells</term> was remarkably inhibited by <term sem="Other" id="T50" lex="ADT_pretreatment"><term sem="Organic_compound_other" id="T51" lex="ADT">ADT</term> pretreatment</term>.</sentence>
<event id="E33">
<type class="Positive_regulation" />
<theme idref="T48" />
<cause idref="T47" />
<clue>H2O2 <clueType>induced</clueType> lipid peroxidation <clueLoc>in Wurzburg cells</clueLoc> was remarkably inhibited by ADT pretreatment.</clue>
</event>
<event id="E34">
<type class="Artificial_process" />
<theme idref="T51" />
<clue>H2O2 induced lipid peroxidation in Wurzburg cells was remarkably inhibited by ADT <clueType>pretreatment</clueType>.</clue>
</event>
<event id="E35">
<type class="Negative_regulation" />
<theme idref="E33" />
<cause idref="E34" />
<clue>H2O2 induced lipid peroxidation in Wurzburg cells was remarkably <clueType>inhibited</clueType> <linkCause>by</linkCause> ADT pretreatment.</clue>
</event>
<sentence id="S11"><term sem="Organic_compound_other" id="T52" lex="ADT">ADT</term>, a <term sem="Organic_compound_other" id="T53" lex="pro-_glutathione_antioxidant">pro-<term sem="Peptide" id="T54" lex="glutathione">glutathione</term> <term sem="Organic_compound_other" id="T55" lex="antioxidant">antioxidant</term></term>, was observed to be capable of modulating <term sem="Other" id="T56" lex="NF-kappa_B_activation"><term sem="Protein_complex" id="T57" lex="NF-kappa_B">NF-kappa B</term> activation</term>.</sentence>
<event id="E36">
<type class="Positive_regulation" />
<theme idref="T57" />
<clue>ADT, a pro-glutathione antioxidant, was observed to be capable of modulating NF-kappa B <clueType>activation</clueType>.</clue>
</event>
<event id="E37">
<type class="Regulation" />
<theme idref="E36" />
<cause idref="T52" />
<clue>ADT, a <corefCause>pro-glutathione antioxidant</corefCause>, was observed to be capable of <clueType>modulating</clueType> NF-kappa B activation.</clue>
</event>
</AbstractText>
</Abstract>
</Article>
</MedlineCitation>
</PubmedArticle>
</PubmedArticleSet>
</Annotation>
